PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR… Application WO-2021048135-A1 World Intellectual Property Organisation (WIPO) 18 Mar 2021